Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 0.00% is 100% above its 5-year average of -5727.77%, near the high end of its 5-year range (-53398.58%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% above its 12-month average of -17799.53%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
-17799.53%
NET PROFIT MARGIN AVG 3Y
-8674.70%
NET PROFIT MARGIN AVG 5Y
-5727.77%
NET PROFIT MARGIN AVG 10Y
-376.45%
NET PROFIT MARGIN AVG 15Y
-246.14%
NET PROFIT MARGIN AVG 20Y
-188.22%
CURRENT VS TTM AVG
+100.00%
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 789 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Incannex Healthcare Limited
Market Cap
$37.71M
Net Profit Margin
0.00%
TTM Avg
-17799.53%
3Y Avg
-8674.70%
5Y Avg
-5727.77%
Market Cap
$37.60M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-322.60%
Market Cap
$37.08M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-479.12%
Market Cap
$38.47M
Net Profit Margin
-11.86%
TTM Avg
-39.34%
3Y Avg
-22.53%
5Y Avg
-16.34%
Market Cap
$35.80M
Net Profit Margin
-65.29%
TTM Avg
-26.68%
3Y Avg
-11.11%
5Y Avg
-8.71%
Market Cap
$35.42M
Net Profit Margin
-65.31%
TTM Avg
-147.78%
3Y Avg
-3852.20%
5Y Avg
-3378.36%
Market Cap
$40.06M
Net Profit Margin
8.38%
TTM Avg
3.43%
3Y Avg
-19.55%
5Y Avg
-29.01%
Market Cap
$40.09M
Net Profit Margin
-689.20%
TTM Avg
-248.90%
3Y Avg
-225.94%
5Y Avg
-1945.52%
Market Cap
$40.28M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Incannex Healthcare Limited (IXHL) | $37.71M | 0.00% | -17799.53% | -8674.70% | -5727.77% |
| Edesa Biotech, Inc. (EDSA)vs › | $37.60M | 0.00% | 0.00% | 0.00% | -322.60% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $37.08M | 0.00% | 0.00% | 0.00% | -479.12% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.47M | -11.86% | -39.34% | -22.53% | -16.34% |
| DocGo Inc. (DCGO)vs › | $35.80M | -65.29% | -26.68% | -11.11% | -8.71% |
| QT Imaging Holdings, Inc. (QTI)vs › | $35.42M | -65.31% | -147.78% | -3852.20% | -3378.36% |
| Nephros, Inc. (NEPH)vs › | $40.06M | 8.38% | 3.43% | -19.55% | -29.01% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.09M | -689.20% | -248.90% | -225.94% | -1945.52% |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.28M | 0.00% | 0.00% | 0.00% | 0.00% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-06-30 | -53398.58% |
| 2024-12-31 | -7324.32% |
| 2024-06-30 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-06-30 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-06-30 | -1234.43% |
| 2021-12-31 | 0.00% |
| 2021-06-30 | -1048.10% |
| 2020-12-31 | -324.65% |
| 2020-06-30 | -1091.80% |
| 2019-12-31 | -30095.27% |
| 2019-06-30 | -274.29% |
| 2018-12-31 | -317.35% |
| 2018-06-30 | -240.19% |
| 2017-12-31 | -475.49% |
| 2017-06-30 | -727.48% |
| 2016-12-31 | -108187.56% |
| 2016-06-30 | -665.85% |
| 2015-12-31 | -3017.26% |
| 2015-06-30 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-06-30 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-06-30 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-06-30 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-06-30 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-06-30 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-06-30 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-06-30 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-06-30 | 0.00% |
